PARTNERSHIP News

Bayer and Iambic Partner to Advance AI-Driven Drug Discovery

Bayer has announced a research collaboration with Iambic Therapeutics to use Iambic's AI-based platform for the discovery of new small molecules. This partnership aims to use Iambic's leading

Insilico Medicine Secures $2.5B AI Drug Discovery Partnership

Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, has announced a significant research and development collaboration with SK Biopharmaceuticals. This partnership, valued

Insilico Medicine Secures $2.5B Partnership with SK Biopharma for AI Drug Discovery

Insilico Medicine announced a landmark $2.5 billion global research and development collaboration with SK Biopharmaceuticals at the BIO International Convention 2026. This strategic alliance aims to d

Insilico Medicine & SK Biopharma in $2.5B AI Drug Discovery Deal

Insilico Medicine has partnered with SK Biopharmaceuticals in a research and development collaboration to discover AI-enabled drug candidates for neuroimmune disorders of the central nervous system. T

Insilico, SK Biopharma Partner for $2.5B AI Drug Discovery in Neuroimmune Disorders

Insilico Medicine and SK Biopharmaceuticals announced a research and development collaboration with a potential value of up to $2.5 billion, including an $18 million upfront payment. This partnership

Greenstone Biosciences and Intel Partner for AI Drug Discovery

Greenstone Biosciences and Intel Corp. Have announced a strategic collaboration to accelerate AI-enabled drug discovery and advance precision medicine. The partnership combines Greenstone's extensive

Greenstone Biosciences and Intel Partner for AI Drug Discovery

Greenstone Biosciences and Intel Corp. Have announced a strategic collaboration to advance human-centric drug discovery. This partnership combines Greenstone's large-scale human induced pluripotent st

Axcelead DDP Joins Lilly TuneLab to Advance AI Drug Discovery

Axcelead Drug Discovery Partners (DDP) has announced a collaboration with Lilly TuneLab, Eli Lilly and Company's AI/ML drug discovery platform. This partnership will see Axcelead DDP contribute propri

Boltz, Takeda Partner to Deploy Frontier AI Models for Drug Discovery

Boltz PBC has announced a collaboration with Takeda to integrate its advanced biomolecular AI models, BoltzMol-1 and BoltzProt-1, across Takeda's research organization. This partnership will provide T

AI Transforms Stem Cell Therapy: Cellular Intelligence Partners with Novo Nordisk

AI-native platforms are reshaping stem-cell therapy development, enabling faster design, testing, and manufacturing of living medicines. Cellular Intelligence is using its AI foundation model, tr

Harbour BioMed & BioMap Launch MegaStream TechBio for AI Drug Discovery

Harbour BioMed and BioMap have announced a multi-dimensional, long-term strategic partnership to launch MegaStream TechBio, a new AI-native pipeline company. This collaboration aims to accelerate the

Harbour BioMed and BioMap Launch MegaStream TechBio for AI-Driven Biologics R&D

Harbour BioMed and BioMap have announced a strategic partnership to jointly launch MegaStream TechBio, a new AI-native pipeline company focused on the AI-driven discovery and development of complex bi

Abridge Partners with Eli Lilly and Nvidia to Expand AI Scribe Platform

Abridge, an AI documentation firm, has announced strategic partnerships with pharmaceutical giant Eli Lilly and technology leader Nvidia. Eli Lilly made a strategic investment to support evidence-base

Abridge, Eli Lilly, Nvidia Forge Partnership for AI Clinical Foundation Models

AI documentation firm Abridge has announced a strategic investment from pharmaceutical giant Eli Lilly and a collaboration with Nvidia to develop a foundation model for clinical conversations. This pa

Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate RNAi Therapeutics Discovery

Alnylam Pharmaceuticals has announced a strategic collaboration with AI biotech Inceptive Nucleics, valued at up to $2 billion, to accelerate the discovery of RNAi therapeutics. The partnership combin

Alnylam Enters $2 Billion Strategic AI Collaboration with Inceptive

Alnylam Pharmaceuticals has announced a strategic collaboration with Inceptive, valued at up to $2 billion, to accelerate the discovery and development of RNA interference (RNAi) therapeutics using ge

Alnylam Strikes $2B AI Deal with Inceptive for RNAi Drug Discovery

Alnylam Pharmaceuticals has entered a strategic partnership with Inceptive, an AI platform for protein engineering, to accelerate the discovery and optimization of RNA interference (RNAi) therapeutics

NVIDIA, Foxconn, and Taiwan Medical Centers Bring AI to 'Healthy Taiwan'

Foxconn is deploying NVIDIA AI across Taiwan's medical centers for the "Healthy Taiwan" initiative, transitioning from individual AI tools to coordinated AI agent workforces. This includes agentic and

MicroPort NeuroScientific & OYMotion Partner on BCI & Exoskeleton

MicroPort NeuroScientific Corporation has formed a strategic partnership with OYMotion Technologies Co., Ltd. For the deep integration of brain-computer interface (BCI) and exoskeleton robot systems.

Hammerspace and Secuvy AI Expand Partnership in Asia-Pacific

Hammerspace, a high-performance data platform for AI, has announced an exclusive strategic partnership with Secuvy across the Asia-Pacific region. This collaboration aims to provide best-in-class AI d

Anthropic Reportedly In Talks With Microsoft To Use Maia AI Chips

Anthropic is reportedly in discussions with Microsoft to use its Maia AI chips as the competition for advanced computing capacity in the artificial intelligence sector intensifies. This potential

Lilly, BMS, Incyte Strike Deals to Keep Biopharma's AI Integration Rolling

Eli Lilly, Bristol Myers Squibb, and Incyte have recently formed new partnerships, further embedding artificial intelligence into their drug development processes. Bristol Myers Squibb partnered with

Incyte expands AI drug discovery pact with Genesis with $120M up front

Incyte has significantly expanded its AI drug discovery partnership with Genesis, committing an $80 million upfront payment and a $40 million equity investment. This deal, valued at over $1 billion wi

QIAGEN and NVIDIA Partner for AI-Driven Drug Discovery Advancement

QIAGEN Digital Insights is integrating NVIDIA's accelerated computing and BioNeMo platform with its picked bioinformatics knowledge to enhance AI in drug discovery. This collaboration aims to help ph

Lilly Partners Profluent for AI-Designed Genetic Medicine Development

Eli Lilly has entered into a multi-program strategic research collaboration with AI company Profluent to develop and commercialize AI-designed site-specific recombinases for genetic medicine. This par

Lilly, AI biotech Profluent ink $2.25B pact in search of genetic medicine 'holy grail'.

Eli Lilly has entered a strategic partnership with AI-driven biotech Profluent, potentially worth up to $2.25 billion, to advance new DNA editing technologies. This collaboration focuses on developing

HK inno.N Partners Atommerce for AI-Based Obesity Drug Discovery

HK inno.N has signed a joint R&D agreement with Atommerce to develop next-generation AI-based obesity treatments. The collaboration will use Atommerce's AI drug design platform 'CANDDIE' to ident

Merck and Google Cloud Partner in $1B AI Enterprise Transformation

Merck and Google Cloud have announced a significant multi-year partnership, valued at up to $1 billion, to integrate an agentic AI platform across Merck's global operations. This collaboration aims to

Tempus AI and Predicta Biosciences Partner for Genomic Assay Expansion

Tempus AI and Predicta Biosciences have announced a commercial partnership to expand access to GenoPredicta, an ultrasensitive whole-genome sequencing assay. This co-branded assay is designed for comp

OpenAI Partners with Novo Nordisk to Accelerate Drug Discovery and Delivery

Artificial intelligence powerhouse OpenAI Group PBC has announced a strategic partnership with pharmaceutical giant Novo Nordisk A/S. This collaboration aims to integrate OpenAI's advanced AI capabili

Noul Partners with US Regenerative Medicine Provider for AI Blood Analysis

AI-based diagnostics company Noul has partnered with U.S. Regenerative medicine provider Infinite Medical to apply its AI-powered blood analysis solution, miLab BCM, in stem cell therapy and regenerat

IQVIA and NVIDIA Partner on AI Platform, Expand Collaborations

IQVIA has rolled out its IQVIA.ai platform, a result of its partnership with NVIDIA, and simultaneously acquired drug discovery assets from Charles River Laboratories while expanding research collabor

AI Unlocks Hidden 98% of Human Genome in Major Research Partnership

Sheba Medical Center, Icahn School of Medicine at Mount Sinai, and NVIDIA have initiated a three-year collaboration to use artificial intelligence and large language models to decode the 98% of th

Regeneron Partners with TriNetX for AI-Driven Drug Discovery and Digital Health

Regeneron Pharmaceuticals has announced a strategic collaboration with TriNetX, including an investment of up to $200 million, to gain exclusive access to TriNetX's network of approximately 300 millio

Flagship Pioneering and AWS Partner to Accelerate AI Drug Discovery

Flagship Pioneering and Amazon Web Services (AWS) have announced a strategic collaboration to accelerate life sciences breakthroughs across Flagship's portfolio companies. The partnership will provide

Eli Lilly Expands Insilico Medicine AI Drug Discovery Deal to $2.75B

Eli Lilly has significantly expanded its partnership with Insilico Medicine, committing up to $2.75 billion for AI-powered drug discovery. This collaboration grants Lilly exclusive worldwide rights to

Eli Lilly Expands $2.75B AI Drug Discovery Partnership with Insilico Medicine

Eli Lilly has significantly expanded its artificial intelligence collaboration with Insilico Medicine in a deal that could reach $2.75 billion. The expanded partnership grants Lilly exclusive global r

Eli Lilly Expands Insilico Medicine AI Drug Discovery Pact to $2.75 Billion

Eli Lilly has broadened its partnership with AI-powered biotech Insilico Medicine, entering a drug discovery and development agreement valued at up to $2.75 billion. The deal includes an upfront payme

Eli Lilly Expands AI Drug Discovery Partnership with Insilico Medicine in $2.75B Deal

Eli Lilly has significantly deepened its collaboration with Insilico Medicine through a new drug discovery and development agreement potentially worth up to $2.75 billion. This partnership grants Lill

Insilico Medicine & Lilly Partner in $2.75B AI Drug Discovery Deal

Insilico Medicine and Eli Lilly and Company have announced a global multi-target research and development collaboration, using Insilico's generative artificial intelligence (AI) platform for drug

Converge Bio Expands AI Antibody Partnership with Purple Biotech

Converge Bio is deepening its collaboration with Purple Biotech on advanced antibody therapeutics, specifically for Purple Biotech's CAPTN-3 tri-specific antibody platform for solid tumors. Converge B

Revvity & Profluent Launch AI-Enhanced Base Editing Access Program

Revvity and Profluent have partnered to introduce an AI-enhanced Base Editing Access Program. This initiative aims to accelerate therapeutic development by providing selected researchers with complime

BioMarin and Deep Genomics Partner on AI for Rare Disease Drug Discovery

BioMarin Pharmaceutical Inc. Announced a new strategic partnership with Deep Genomics, an AI-driven drug discovery company. The collaboration aims to use Deep Genomics' AI platform to identify an

Insilico Medicine Expands AI-Driven CNS Drug Discovery Partnership

Insilico Medicine, a clinical-stage generative AI biotechnology company, and Tenacia Biotechnology have expanded their AI-driven R&D collaboration for central nervous system (CNS) therapeutics. The ex

Purple Biotech, Converge Bio Partner on AI Tri-Specific Antibody Design

Purple Biotech has announced a collaboration with Converge Bio to use advanced generative AI for designing and optimizing its next-generation tri-specific antibody platform for oncology. This part

Purple Biotech Partners with Converge Bio for AI-Driven Antibody Design

Purple Biotech Ltd. Has announced a strategic collaboration with Converge Bio to use its generative AI platform for the accelerated design and optimization of next-generation tri-specific antibod

Tecan and NVIDIA Partner to Create AI-Driven Laboratories

Tecan and NVIDIA have announced a strategic partnership to integrate AI directly into laboratory workflows, aiming to transform raw laboratory data into actionable insights and improve lab efficiency.

Insilico, ASKA Partner for AI-Driven Gynecological Drug Discovery

Insilico Medicine has announced a strategic research collaboration with ASKA Pharmaceutical Co., Ltd. To identify novel therapeutic targets for challenging gynecological conditions such as endometrios

Ainnocence calls for global collaboration on AI-driven antibody and vaccine discovery

Ainnocence Inc. Is advocating for worldwide collaboration to use its generative AI platform for accelerated discovery of antibodies and vaccines targeting infectious diseases. The company's platfo

Science Corp and Neurosoft unite to speed brain-computer care

Science Corporation and Neurosoft Bioelectronics have formed a new partnership to reduce the cost and accelerate the development of brain-computer interface (BCI) therapies. This collaboration aims to

Merck and Mayo Clinic Launch AI-Driven Precision Medicine Lab

Merck and Mayo Clinic have initiated a strategic collaboration to integrate multimodal clinical data with AI, aiming to accelerate drug discovery and target identification. This partnership will utili

Insilico Medicine and Liquid AI Partner for Lightweight AI Drug Discovery Models

Insilico Medicine and Liquid AI have announced a strategic partnership to develop lightweight scientific foundation models for pharmaceutical research. Their collaboration has yielded LFM2-2.6B-MMAI (

Verily and Google Cloud Unite to Boost AI for Biomedical Research

Verily, an Alphabet company focused on life sciences, has announced a strategic partnership with Google Cloud to integrate their AI and machine learning capabilities into biomedical research. This col

Science Corp. & Neurosoft Bioelectronics Partner on BCI System

Science Corp. And Neurosoft Bioelectronics have announced a strategic partnership to develop brain-computer interface (BCI) products, aiming to accelerate clinical adoption and reduce development cost

Merck and Mayo Clinic Partner on AI to Accelerate MS Drug Discovery

Merck and Mayo Clinic have announced a research collaboration aimed at using artificial intelligence and large-scale clinical data to expedite drug discovery and development, with an initial focus